N/A
N=483
Perioperative Management of Patients With Coronary Stents Undergoing Noncardiac Surgery
Acute Coronary Syndrome · Coronary Stent Occlusion · Surgery
Bottom Line
View on ClinicalTrials.gov: NCT01171612 ↗Enrolled (actual)
483
Serious AEs
14.1%
Results posted
Nov 2013
Primary outcome: Primary: Major Adverse Cardiac and Cerebrovascular Events (MACCEs) — 63 participants
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- —
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Corporacion Parc Tauli
- Primary completion
- Feb 2010
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Major Adverse Cardiac and Cerebrovascular Events (MACCEs) |
63 | — |
| SECONDARY Major Haemorrhagic Events |
161 | — |
| SECONDARY Number of Patients With Adverse Events Related With Antiplatelet Therapy Management |
38; 10; 9 | 0.479 |
Summary
The purpose of this study is to evaluate and monitor perioperative management of patients with coronary stents undergoing noncardiac surgery.
Objectives:
* To describe the incidence and severity of adverse cardiovascular events in patients with coronary stents undergoing noncardiac surgery with admission.
* To assess the following-up of the guidelines about the perioperative management of antiplatelet therapy in these patients.
* To assess the relationship between the incidence of cardiac or neurovascular events, as well as bleeding complications with the perioperative management of antiplatelet therapy.
* Number of Participants with Adverse Events as a Measure of Safety
Eligibility Criteria
Inclusion Criteria
- > 18 years old, with coronary stents
- American Society of Anaesthesia physical status II-V
- noncardiac surgery wiht admission
- informed consent
Exclusion Criteria
- < 18 years old
- American Society of Anaesthesia physical status I
- ambulatory surgery
- pregnancy
- obstetric anaesthesia
- endoscopic procedures
- cardiac surgery
- not informed consent
Data sourced from ClinicalTrials.gov (NCT01171612). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.